Play

A simple blood test may soon help precisely identify your risk for Alzheimer’s disease by inducing some of your cells to go back in time, looking like they did when you were an embryo. Johns Hopkins cell engineering expert Vasiliki …

What might reprogramming cells have to do with understanding Alzheimer’s? Elizabeth Tracey reports Read more »

Play

Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …

Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read more »

Play

The FDA has recently removed black box warnings, indicating a medication is potentially risky, from hormone therapy for menopause. The warning was originally put on in 2003 after a study seemed to show increased risks for cardiovascular disease, breast cancer …

What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports Read more »

Play

If you’re a woman who’s experiencing a loss of libido, you may have been advised to take testosterone supplements, but Wen Shen, a menopause expert at Johns Hopkins, says wholesale embrace of hormone therapy isn’t for everyone, in spite of …

Women need to exercise caution when it comes to hormones of all types, Elizabeth Tracey reports Read more »

Play

Hormone therapy is not a panacea for everything that happens to a women transitioning through menopause, cautions Wen Shen, a menopause expert at Johns Hopkins. Now that the FDA has removed their black box warning from many forms of hormone …

What are the benefits of hormone therapy for women in menopause and perimenopause? Elizabeth Tracey reports Read more »

Play

Certain hormone therapies for menopause have had black box warnings on them since 2003, following concerns arising from the Women’s Health Initiative study, which seemed to show increased risks for breast cancer and dementia. Now the FDA has removed these …

What might the FDA’s removal of a black box warning on hormone therapy for menopause mean to you? Elizabeth Tracey reports Read more »

Play

Using one of two drug combinations versus ibrutinib alone to treat chronic lymphocytic leukemia, one of the most common types of leukemia in adults, may allow people to avoid continuous treatment, a new study finds.  William Nelson, director of the Kimmel …

A couple new approaches to treating a type of leukemia may help shorten treatment, Elizabeth Tracey reports Read more »